The role of estrogen in cardiovascular disease

Lauren Baker, Kirstan K. Meldrum, Meijing Wang, Rajakumar Sankula, Ram Vanam, Azad Raiesdana, Ben Tsai, Karen Hile, John Brown, Daniel R. Meldrum

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Cardiovascular disease is the number one cause of death among women, accounting for nearly 50% of female deaths. Statistics show that women on average develop cardiovascular disease 10 to 15 years later in life than men, and that the risk may increase after menopause. This observation has led to much speculation as to what physiological change(s) associated with menopause is responsible for the higher risk of atherosclerosis. Estrogen, with its potential as a cardioprotective agent and as an immunomodulator of the inflammatory response in atherosclerosis, has received the most attention. Understanding the mechanisms that lead to these differences may allow beneficial therapeutic intervention to enhance this effect in females and evoke this protection in males. This review will do the following: (1) characterize mechanisms of atherosclerosis, (2) explore the role of estrogen-replacement therapy, (3) define the effect of gender on inflammation, (4) compare and contrast the effects of estrogen and testosterone on endothelial functional, and (5) suggest mechanistic based therapeutic opportunities.

Original languageEnglish
Pages (from-to)325-344
Number of pages20
JournalJournal of Surgical Research
Volume115
Issue number2
DOIs
StatePublished - Dec 2003

Fingerprint

Atherosclerosis
Estrogens
Cardiovascular Diseases
Menopause
Cardiotonic Agents
Estrogen Replacement Therapy
Immunologic Factors
Testosterone
Cause of Death
Inflammation
Therapeutics

Keywords

  • Cardiovascular disease
  • Estrogen-replacement therapy
  • Menopause

ASJC Scopus subject areas

  • Surgery

Cite this

Baker, L., Meldrum, K. K., Wang, M., Sankula, R., Vanam, R., Raiesdana, A., ... Meldrum, D. R. (2003). The role of estrogen in cardiovascular disease. Journal of Surgical Research, 115(2), 325-344. https://doi.org/10.1016/S0022-4804(03)00215-4

The role of estrogen in cardiovascular disease. / Baker, Lauren; Meldrum, Kirstan K.; Wang, Meijing; Sankula, Rajakumar; Vanam, Ram; Raiesdana, Azad; Tsai, Ben; Hile, Karen; Brown, John; Meldrum, Daniel R.

In: Journal of Surgical Research, Vol. 115, No. 2, 12.2003, p. 325-344.

Research output: Contribution to journalArticle

Baker, L, Meldrum, KK, Wang, M, Sankula, R, Vanam, R, Raiesdana, A, Tsai, B, Hile, K, Brown, J & Meldrum, DR 2003, 'The role of estrogen in cardiovascular disease', Journal of Surgical Research, vol. 115, no. 2, pp. 325-344. https://doi.org/10.1016/S0022-4804(03)00215-4
Baker L, Meldrum KK, Wang M, Sankula R, Vanam R, Raiesdana A et al. The role of estrogen in cardiovascular disease. Journal of Surgical Research. 2003 Dec;115(2):325-344. https://doi.org/10.1016/S0022-4804(03)00215-4
Baker, Lauren ; Meldrum, Kirstan K. ; Wang, Meijing ; Sankula, Rajakumar ; Vanam, Ram ; Raiesdana, Azad ; Tsai, Ben ; Hile, Karen ; Brown, John ; Meldrum, Daniel R. / The role of estrogen in cardiovascular disease. In: Journal of Surgical Research. 2003 ; Vol. 115, No. 2. pp. 325-344.
@article{a666f6d6bb7c4a8185dc5f7704f8b535,
title = "The role of estrogen in cardiovascular disease",
abstract = "Cardiovascular disease is the number one cause of death among women, accounting for nearly 50{\%} of female deaths. Statistics show that women on average develop cardiovascular disease 10 to 15 years later in life than men, and that the risk may increase after menopause. This observation has led to much speculation as to what physiological change(s) associated with menopause is responsible for the higher risk of atherosclerosis. Estrogen, with its potential as a cardioprotective agent and as an immunomodulator of the inflammatory response in atherosclerosis, has received the most attention. Understanding the mechanisms that lead to these differences may allow beneficial therapeutic intervention to enhance this effect in females and evoke this protection in males. This review will do the following: (1) characterize mechanisms of atherosclerosis, (2) explore the role of estrogen-replacement therapy, (3) define the effect of gender on inflammation, (4) compare and contrast the effects of estrogen and testosterone on endothelial functional, and (5) suggest mechanistic based therapeutic opportunities.",
keywords = "Cardiovascular disease, Estrogen-replacement therapy, Menopause",
author = "Lauren Baker and Meldrum, {Kirstan K.} and Meijing Wang and Rajakumar Sankula and Ram Vanam and Azad Raiesdana and Ben Tsai and Karen Hile and John Brown and Meldrum, {Daniel R.}",
year = "2003",
month = "12",
doi = "10.1016/S0022-4804(03)00215-4",
language = "English",
volume = "115",
pages = "325--344",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - The role of estrogen in cardiovascular disease

AU - Baker, Lauren

AU - Meldrum, Kirstan K.

AU - Wang, Meijing

AU - Sankula, Rajakumar

AU - Vanam, Ram

AU - Raiesdana, Azad

AU - Tsai, Ben

AU - Hile, Karen

AU - Brown, John

AU - Meldrum, Daniel R.

PY - 2003/12

Y1 - 2003/12

N2 - Cardiovascular disease is the number one cause of death among women, accounting for nearly 50% of female deaths. Statistics show that women on average develop cardiovascular disease 10 to 15 years later in life than men, and that the risk may increase after menopause. This observation has led to much speculation as to what physiological change(s) associated with menopause is responsible for the higher risk of atherosclerosis. Estrogen, with its potential as a cardioprotective agent and as an immunomodulator of the inflammatory response in atherosclerosis, has received the most attention. Understanding the mechanisms that lead to these differences may allow beneficial therapeutic intervention to enhance this effect in females and evoke this protection in males. This review will do the following: (1) characterize mechanisms of atherosclerosis, (2) explore the role of estrogen-replacement therapy, (3) define the effect of gender on inflammation, (4) compare and contrast the effects of estrogen and testosterone on endothelial functional, and (5) suggest mechanistic based therapeutic opportunities.

AB - Cardiovascular disease is the number one cause of death among women, accounting for nearly 50% of female deaths. Statistics show that women on average develop cardiovascular disease 10 to 15 years later in life than men, and that the risk may increase after menopause. This observation has led to much speculation as to what physiological change(s) associated with menopause is responsible for the higher risk of atherosclerosis. Estrogen, with its potential as a cardioprotective agent and as an immunomodulator of the inflammatory response in atherosclerosis, has received the most attention. Understanding the mechanisms that lead to these differences may allow beneficial therapeutic intervention to enhance this effect in females and evoke this protection in males. This review will do the following: (1) characterize mechanisms of atherosclerosis, (2) explore the role of estrogen-replacement therapy, (3) define the effect of gender on inflammation, (4) compare and contrast the effects of estrogen and testosterone on endothelial functional, and (5) suggest mechanistic based therapeutic opportunities.

KW - Cardiovascular disease

KW - Estrogen-replacement therapy

KW - Menopause

UR - http://www.scopus.com/inward/record.url?scp=0346433814&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346433814&partnerID=8YFLogxK

U2 - 10.1016/S0022-4804(03)00215-4

DO - 10.1016/S0022-4804(03)00215-4

M3 - Article

VL - 115

SP - 325

EP - 344

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -